community
Adze Biotechnology — Oak Park, Illinois
Adze specializes in oncolytic immunotherapy: a type of cancer treatment that creates targeted immune evasion viruses that block proteins to tumors and kill cancer cells. Adze’s oncolytic vectors kill cancer cells directly by exposing cancer antigens to the immune system while stimulating the person’s immune response. The company’s technology hopes to add…
Read more
tales from the trenches
At our September Tales from the Trenches™, Prashant Srivastava joined us to share stories from the past 12 years at the helm of Evive.
Prashant built Evive in 2007 with his co-founder, Peter Saravis, with the understanding that when employees live healthier lives, they produce better work. The company uses consumer-focused predictive analytics to provide employees with the right benefits inf…
Read more
community
Every day, innovators across the MATTER community are building new solutions that accelerate innovation, advance care and improve lives. Here’s a look into the most noteworthy headlines from September.
Catalia Health teams up with Pfizer to pilot patient engagement robot
Catalia Health and Pfizer have launched a one year pilot study to explore how patients engage with artificial intelligence …
Read more
stories that matter
For most families, holidays and social events — like Halloween — are a time to relax. But for parents of the 5.6 million American children living with food allergies, relaxing during any event that involves food is nearly impossible.
“A lot of stress comes with holidays, a lot of stress comes with events, and it’s up to us — and it’s up to our community — to rally around that. It really takes …
Read more
stories that matter
Every day for the next 19 years, 10,000 people in the United States will turn 65.
This major demographic shift is one of the reasons that Advocate Aurora Health, a MATTER partner and one of the largest not-for-profit hospital systems in the U.S., has committed to reimagining how they care for aging adults — inside and outside of clinical settings.
In a recent conversation at MATTER, Nicole Pa…
Read more